Search

everythinglearnresearchcommunity

for

Search:↓

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

Post-COVID-19 patients are at risk for hair loss.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

Older males had higher death rates, and Latin Americans were more often in the ICU during the COVID-19 outbreak in a Spanish hospital.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Pomegranate has health benefits and new methods are improving its use in supplements.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

The treatment might help COVID-19 related hair loss, but more research is needed.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

The study found that in Eclipta prostrata roots, coumestans come from acetate and shikimate pathways, and phenylpropanoid is made only through the shikimate pathway.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

Lower Gas6 and sAxl levels are linked to hair loss in COVID-19 survivors.

A compound from Sansevieria trifasciata shows strong antibacterial effects against E. coli and S. aureus.

Vitamin D3 deficiency can worsen psoriasis by promoting Candida overgrowth.

Essential oils may improve dogs' health and melatonin can help with their sleep and anxiety, but both should be used carefully.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

New technologies replicate human skin for testing without animals.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

The machine learning model accurately detected hair loss and scalp diseases using processed images.